Shopping Cart
Remove All
Your shopping cart is currently empty
TG2-179-1 is a BRCA1-associated protein 1 (BAP1) inhibitor with potential anticancer activity. TG2-179-1 exhibits potent cytotoxic activity against colon cancer cells and induces apoptosis. TG2-179-1 can be used in colon cancer research. TG2-179-1 is a BRCA1-associated protein 1 (BAP1) inhibitor with potential anticancer activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $287 | 35 days | 35 days | |
| 5 mg | $1,130 | 35 days | 35 days | |
| 10 mg | $1,980 | 35 days | 35 days |
| Description | TG2-179-1 is a BRCA1-associated protein 1 (BAP1) inhibitor with potential anticancer activity. TG2-179-1 exhibits potent cytotoxic activity against colon cancer cells and induces apoptosis. TG2-179-1 can be used in colon cancer research. TG2-179-1 is a BRCA1-associated protein 1 (BAP1) inhibitor with potential anticancer activity. |
| Molecular Weight | 484.95 |
| Formula | C22H14ClFN4O2S2 |
| Cas No. | 1135023-19-6 |
| Smiles | N#CC1=C(SC(=C1C2=CC=C(F)C=C2)C)NC(=O)CSC3=NN=C(O3)C=4C=CC(Cl)=CC4 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| Solubility Information | DMF: 1 mg/mL (2.06 mM), Sonication is recommended. Ethanol: 1 mg/mL (2.06 mM), Sonication is recommended. DMSO: 1 mg/mL (2.06 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMF/Ethanol/DMSO
| |||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.